Dynamic changes of IFN-γ-producing cells, TGF-β and their predictive value in early outcomes of renal transplantation

International Journal of Organ Transplantation Medicine

Volumn 4, Issue 2, 2013, Pages 77-85

  Mohammadi, F ^a   Niknam, M H ^a   Nafar, M ^b   Einollahi, B ^c   Nazari, B ^a   Lessanpezeshki, M ^a   Amirzargar, M A ^d   Solgi, G ^d   Nikbin, B ^a   Amirzargar, A A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allograft; Ifn ; Kidney; Tgf

Indexed keywords

GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INCIDENCE; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84876800749     PISSN: 20086490     EISSN: 20086482     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Nickel P, Presber F. Bold G, et al. Enzyme linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal transplant recipients. Transplant 2004;78:1640-6.
2. Hricik DE, Rodriguez V, Riley J, et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003;3:878-84.
3. Yates PJ, Nicholson ML. The a etiology and pathogenesis of chronic allograft nephropathy. Transpl Immunol 2006;16:148.
4. Mittal SK, Sharma RK, Gupta A, Naik S. I increased interleukin-10 production without expansion of CD4+ CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors. Transplant 2009;88:435-41.
5. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFNgamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999;163:2267-75.
6. Najafian N, Salama AD, Fedoseyeva EV, et al. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002;13:252-9.
7. Tary-Lehmann M, Hricik DE, Justice AC, et al. Enzyme-linked immunosorbent assay spot detection of interferon-gamma and interleukin 5-producing cells as a predictive marker for renal allograft failure. Transplant 1998;66:219-24.
8. Ranjbar M, Solgi G, Mohammadnia M, et al. Regulatory T-cell subset analysis and profile of interleukin (IL)-10, IL-17 and interferon-gamma cytokine-producing cells in kidney allograft recipients with donor cells infusion. Clin Exp Nephrol 2012;16:636-46.
9. Cornell LD, Smith RN, Colvin RB. Kidney Transplantation: Mechanisms of Rejection and Acceptance. Annu Rev Pathol 2008;3:189-220.
10. Solgi G, Amirzagar AA, Pourmand G, et al. TH1/ TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion. Transplant Proc 2009;41:2800-4.
11. Mohammadnia M, Solgi G, Ranjbar M, et al. Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-β1, and interferon-γ cytokines and expression levels of IL-10 and TGF-β1 genes in renal allograft recipients after donor bone marrow cell infusion. Transplant Proc 2011;43:495-9.
12. Ring GH, Saleem S, Dai Z, et al. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplant 1999;67:1362-5.
13. Halloran PF, Miller LW, Urmson J, et al. IFN-γ alters the pathology of graft rejection: protection from early necrosis. J Immunol 2001;166:7072-81.
14. Halloran PF, Afrouzian M, Ramassar V, et al. Interferon-γ acts directly on rejecting renal allografts to prevent graft necrosis. Am J Pathol 2001;158:215-26.
15. Wang H, DeVries ME, Deng S, et al. The axis of interleukin 12 and γ interferon regulates acute vascular xenogeneic rejection. Nat Med 2000;6:549-55.
16. Hidalgo LG, Urmson J, Halloran PF. IFN-γ decreasesCTLgeneration by limiting IL-2 production: a feedback loop controlling effector cell production. Am J Transplant 2005;5:651-61.
17. P Nickel, G Bold, F Presber et al. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl Immunol 2009;20:238-42.
18. Tiemessen M, Kunzmann S, Schmidt-Weber C, et al. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response. Int Immunol 2003;15:1495-504.
19. Park JY, Park MH, Park H, et al. TNF-alpha and TGFbeta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens, 2004;64:660-6.
20. Pribylova-Hribova P, Kotsch K, Lodererova A, et al. TGF-beta1 mRNA upregulation influences chronic renal allograft dysfunction. Kidney Int 2006;69:1872-9.
21. Brunet M. Cytokines as predictive biomarkers of alloreactivity. Clin Chim Acta 2012;413:1354-8.
22. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008;8:753-60.
23. Sonkar GK, Usha R, Singh G. Is Serum Transforming Growth Factor beta-1 Superior to Serum Creatinine for assessing Renal Failure and Renal Transplant Rejection. JK Science 2009;11:62-6
24. Shurin MR, Lu L, Kalinski P, et al., Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999;21:339-59.
25. Gurkan Tellioglu, Gulbu Isitmang il, et al. Immunomonitorizatiom of cytokine: renal transplant patient in tolerane or rejection. Adv Mol Med 2007;3.